Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Alvarez, M Lucrecia ^a   DiStefano, Johanna K ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA 1; FIBRONECTIN; GLUCOSE; MESSENGER RNA; PLASMACYTOMA VARIANT TRANSLOCATION 1 GENE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR PROTEIN; UNCLASSIFIED DRUG; PROTEIN; PVT1 PROTEIN, HUMAN; SCLEROPROTEIN;

ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENOTYPE; HUMAN; HUMAN CELL; KIDNEY FAILURE; MESANGIUM CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; RNA INTERFERENCE; UPREGULATION; BIOLOGICAL MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY;

DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; HUMANS; MESANGIAL CELLS; MODELS, BIOLOGICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79955544721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018671     Document Type: Article

References (49)

1. U.S.R.D.S. (2002) United States Renal Data System Annual Data Report: Atlas of End-Stage Renal Disease in the United States Bethesda National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases pp. 296-322.
2. Jones CAKA, Rogus J, Xue JL, Collins A, Warram JH, (2005) Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int 67: 1684-1691.
3. Nelson RG, Knowler WC, Pettitt DJ, Hanson RL, Bennett PH, (1995) Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 18: 182-187.
4. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R, (1998) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158: 998-1004.
5. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC, (1990) Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33: 438-443.
6. Quinn M, Angelico MC, Warram JH, Krolewski AS, (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945.
7. Seaquist ER, Goetz FC, Rich S, Barbosa J, (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165.
8. Craig DW, Millis MP, DiStefano JK, (2009) Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes. Diabet Med 26: 1090-1098.
9. Hanson RL, Craig DW, Millis MP, Yeatts KA, Kobes S, et al. (2007) Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study. Diabetes 56: 975-983.
10. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, et al. (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58: 1403-1410.
11. Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, et al. (2005) Genetic Variations in the Gene Encoding ELMO1 Are Associated With Susceptibility to Diabetic Nephropathy. Diabetes 54: 1171-1178.
12. Millis MP, Bowen D, Kingsley C, Watanabe RM, Wolford JK, (2007) Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 56: 3027-3032.
13. Graham M, Adams JM, (1986) Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. Embo J 5: 2845-2851.
14. Mengle-Gaw L, Rabbitts TH, (1987) A human chromosome 8 region with abnormalities in B cell, HTLV-I+ T cell and c-myc amplified tumours. Embo J 6: 1959-1965.
15. Shtivelman E, Bishop JM, (1989) The PVT gene frequently amplifies with MYC in tumor cells. Mol Cell Biol 9: 1148-1154.
16. Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, et al. (2007) Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13: 5745-5755.
17. Ausiello DA, Kreisberg JI, Roy C, Karnovsky MJ, (1980) Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest 65: 754-760.
18. Blantz RC, Konnen KS, Tucker BJ, (1976) Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57: 419-434.
19. Haneda M, Koya D, Isono M, Kikkawa R, (2003) Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol 14: 1374-1382.
20. Mason RM, Wahab NA, (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373.
21. Steffes MW, Osterby R, Chavers B, Mauer SM, (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081.
22. Ayo SH, Radnik RA, Glass WF 2nd, Garoni JA, Rampt ER, et al. (1991) Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260: F185-191.
23. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, et al. (1991) Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34: 198-200.
24. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN, (1998) Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Kidney Int 54: 1107-1116.
25. Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, et al. (2005) Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int 67: 1762-1771.
26. Oh JH, Ha H, Yu MR, Lee HB, (1998) Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int 54: 1872-1878.
27. Tada H, Tsukamoto M, Ishii H, Isogai S, (1994) A high concentration of glucose alters the production of tPA, uPA and PAI-1 antigens from human mesangial cells. Diabetes Res Clin Pract 24: 33-39.
28. Wahab NA, Harper K, Mason RM, (1996) Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem J 316 (Pt 3): 985-992.
29. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN, (1992) High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42: 647-656.
30. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN, (2000) Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11: 2222-2230.
31. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, et al. (2007) MicroRNA silencing through RISC recruitment of eIF6. Nature 447: 823-828.
32. Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, et al. (2007) An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 129: 1141-1151.
33. Maroney PA, Yu Y, Fisher J, Nilsen TW, (2006) Evidence that microRNAs are associated with translating messenger RNAs in human cells. Nat Struct Mol Biol 13: 1102-1107.
34. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA, (2006) Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21: 533-542.
35. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R, (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7: 719-723.
36. Rossi JJ, (2005) RNAi and the P-body connection. Nat Cell Biol 7: 643-644.
37. Sen GL, Blau HM, (2005) Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 7: 633-636.
38. Kim DH, Saetrom P, Snove O Jr, Rossi JJ, (2008) MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A 105: 16230-16235.
39. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
40. Kim VN, Han J, Siomi MC, (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139.
41. Heneghan HM, Miller N, Kerin MJ, (2010) Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11: 354-361.
42. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
43. Poy MN, Spranger M, Stoffel M, (2007) microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab 9 (Suppl 2): 67-73.
44. Kato M, Arce L, Natarajan R, (2009) MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 4: 1255-1266.
45. Kato M, Putta S, Wang M, Yuan H, Lanting L, et al. (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889.
46. Kato M, Zhang J, Wang M, Lanting L, Yuan H, et al. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104: 3432-3437.
47. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, et al. (2008) MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. Faseb J 22: 4126-4135.
48. Huppi K, Volfovsky N, Runfola T, Jones TL, Mackiewicz M, et al. (2008) The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res 6: 212-221.
49. McLennan SV, Fisher E, Martell SY, Death AK, Williams PF, et al. (2000) Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int Suppl 77: S81-87.